Akebia Therapeutics (AKBA) Profit Margin (2016 - 2026)
Akebia Therapeutics (AKBA) profit margin from Dec 31, 2016 to Mar 31, 2026. The current Akebia Therapeutics (AKBA) profit margin is -16.90%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Profit Margin
Quarterly Profit Margin
Annual Profit Margin change of Akebia Therapeutics (AKBA)
| Year | Profit Margin | Change |
|---|---|---|
| 2025 | -2.26% | -94.78% |
| 2024 | -43.33% | +62.43% |
| 2023 | -26.68% | -15.70% |
| 2022 | -31.65% | -1.77% |
| 2022 | -32.22% | -75.67% |
| 2021 | -132.43% | -0.62% |
| 2021 | -133.25% | +352.29% |
| 2020 | -29.46% | -77.44% |
| 2020 | -130.61% | +56.46% |
| 2019 | -83.48% | +20.78% |
| 2018 | -69.12% | +70.04% |
| 2017 | -40.65% | -99.54% |
| 2016 | -8814.94% | N/A |
Comparison Akebia Therapeutics (AKBA) profit margin with competitors
Akebia Therapeutics (AKBA) profit margin is -16.90%.